Y-mAbs Therapeutics Inc. Stock Forecast

Y-mAbs Therapeutics Inc. stock upgraded to Strong Buy Candidate.
(Updated on May 02, 2024)

YMAB Signals & Forecast

Mostly positive signals in the chart today. The Y-mAbs Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $15.61 and $15.20. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, March 18, 2024, and so far it has risen 25.36%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. The stock had a Golden Star Signal on Tuesday, April 30, 2024 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Y-mAbs Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $14.89 and $14.88. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Y-mAbs Therapeutics Inc. finds support just below today's level at $14.89. If this is broken, then the next support from accumulated volume will be at $14.88 and $14.36.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.10 between high and low, or 6.72%. For the last week, the stock has had daily average volatility of 6.58%.

Our recommended stop-loss: $16.75 (-2.92%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 79 and this increases the risk substantially. There is a buy signal from a pivot bottom found 32 days ago.)

Trading Expectations (YMAB) For The Upcoming Trading Day Of Friday 3rd

For the upcoming trading day on Friday, 3rd we expect Y-mAbs Therapeutics Inc. to open at $16.98, and during the day (based on 14 day Average True Range), to move between $16.27 and $18.23, which gives a possible trading interval of +/-$0.98 (+/-5.69%) up or down from last closing price. If Y-mAbs Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 11.38% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $17.33 (0.46%) than the support at $14.89 (13.68%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Y-mAbs Therapeutics Inc. stock A Buy?

Y-mAbs Therapeutics Inc. holds several positive signals and is considered to be a good choice at current levels. We expect the Y-mAbs Therapeutics Inc. stock to perform great in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 5.589 Strong Buy Candidate Upgraded

Predicted Opening Price for Y-mAbs Therapeutics Inc. of Friday, May 3, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.